Emergent BioSolutions Inc. revenue for the last year amounted to 1.05 B USD, the most of which — 497.30 M USD — came from its highest performing source at the moment, Commercial Products. The greatest contribution to the revenue figure was made by United States — last year it brought Emergent BioSolutions Inc. 607.20 M USD, and the year before that — 889.50 M USD.